Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa - a Prospective Randomized Sham-controlled Trial - the RAGE Study

NCT03518905 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03518905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03518905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa - a Prospective Randomized Sham-controlled Trial - the RAGE Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Unknown status
Start date
April 16, 2018
Completion date
December 16, 2020
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus disorder